Related Experiment Video
Updated: Jun 23, 2026
07:06
Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients
Published on: March 29, 2022
Intraocular lens calculation in extreme myopia.
1University Eye Hospital, Wuerzburg, Germany. w.haigis@augenklinik.uni-wuerzburg.de
Journal of Cataract and Refractive Surgery
|April 28, 2009
Summary
Intraocular lens (IOL) calculation formulas require different constants for plus and minus lenses due to significant changes in lens geometry. This is crucial for accurate refractive outcomes, especially in cases of extreme myopia with varying axial lengths.
Area of Science:
- Ophthalmology
- Optical Engineering
Background:
- Intraocular lens (IOL) calculation formulas are essential for refractive surgery.
- Extreme myopia presents challenges due to long axial lengths (AL).
- Changes in IOL geometry between positive and negative power lenses can affect calculations.
Purpose of the Study:
- To theoretically analyze the impact of varying axial lengths on IOL calculation formulas.
- To investigate problems arising from geometric changes in IOLs when transitioning between plus and minus powers.
Main Methods:
- Comparison of thick-lens and thin-lens approaches for IOL calculations.
- Inclusion of IOL constants and analysis of MA60MA IOL design data.
- Use of ray tracing to model eyes and determine IOL constants with the Haigis formula.
Main Results:
- An equation was derived linking IOL geometry (principal plane positions) to effective thin-lens position and IOL constants.
- Significant changes in IOL geometry at the plus-to-minus power transition necessitate adjusted IOL constants.
- Failure to account for these geometric changes can lead to refractive errors that increase with axial length for minus-power IOLs.
Conclusions:
- Different sets of IOL constants are required for plus-power and minus-power intraocular lenses.
- Accurate IOL power calculation necessitates accounting for lens geometry variations.
Related Concept Videos
01:16Focusing of Light in the Eye
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...